Streetbeat News

Regulatory

GOOG

GOOGL

Google's new FCC filing hints at a potential upgrade for the Nest Thermostat, featuring Wi-Fi, Bluetooth, and 60GHz radar. This could be a successor to the high-end Nest Learning Thermostat or a refresh of the entry-level model.

Portfolio Pulse from Ananya Gairola

June 18, 2024 | 11:52 am

MRK

Merck shares are trading higher after the FDA approved CAPVAXIVE for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:39 am

BBIO

BridgeBio Pharma has surpassed its interim analysis enrollment target for its Phase 3 FORTIFY study of BBP-418 for Limb-girdle Muscular Dystrophy Type 2I/R9, with top-line results expected in 2025. The company is considering pursuing Accelerated Approval for BBP-418 following recent interactions with the FDA.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:36 am

PHIO

Phio Pharmaceuticals has been granted a patent in South Korea for its Intasyl compound, which targets photo-aging in skin care.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:34 am

SYRE

Spyre Therapeutics has started dosing healthy volunteers in its first clinical trial of SPY001 for Inflammatory Bowel Disease. Interim pharmacokinetic and safety data are expected by the end of 2024. SPY002 is set to begin first-in-human studies in the second half of 2024. All three next-generation antibodies are on track to be in the clinic within 12 months.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:33 am

AVGO

LEN

LZB

NEE

QQQ

SPY

Wall Street is showing mixed signals with tech stocks poised for a strong start, while the Dow and S&P 500 futures are slightly down. The market's direction will depend on upcoming retail sales data and Federal Reserve speeches. Analysts remain optimistic about the market's upward momentum, driven by potential Fed rate cuts and an AI-related stock rally. Key stocks in focus include La-Z-Boy, Lennar Corp, Broadcom, and NextEra Energy.

Portfolio Pulse from Shanthi Rexaline

June 18, 2024 | 11:31 am

ZNTL

Zentalis Pharmaceuticals shares are trading lower after the FDA placed a partial clinical hold on ZN-c3-001, DENALI, and TETON monotherapy studies of Azenosertib following two recent deaths due to presumed sepsis in the DENALI study.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:29 am

ZNTL

Trading halt status for Zentalis Pharmaceuticals (ZNTL) was updated at 7:25:00 AM ET. The company is expected to resume trading following the release of news and resumption times.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:25 am

PYPD

PolyPid provides an update on its SHIELD II trial, which aims to address the rising rates of surgical site infections (SSIs) post-COVID. With 250 out of 600 patients enrolled, an unblinded interim analysis will be conducted after 400 patients complete their 30-day follow-up. Top-line results are expected in Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 11:18 am

STLA

Stellantis NV (NYSE:STLA) is recalling over 1 million vehicles in the U.S. due to an issue with the rearview camera image display. The recall affects various models including Dodge Durango, Chrysler Pacifica, and Jeep Grand Cherokee L. Dealers will update the radio software free of charge.

Portfolio Pulse from Anan Ashraf

June 18, 2024 | 11:17 am